Michael D. Knudsen

Palle Juul Jensens Boulevard 99
Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Single-Cell Multi-Omics Identifies Measurable Residual Disease Targets Among Myelodysplasia- and Clonal Hematopoiesis-Related Genes in Acute Myeloid Leukemia.

Single-Cell Multi-Omics Identifies Measurable Residual Disease Targets Among Myelodysplasia- and Clonal Hematopoiesis-Related Genes in Acute Myeloid Leukemia.

Journal: Cancers

Published: January 16, 2026

Differences in tumor mutational burden assessment: a national ring trial.

Differences in tumor mutational burden assessment: a national ring trial.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 18, 2025

Differences in tumor mutational burden assessment: a national ring trial.

Differences in tumor mutational burden assessment: a national ring trial.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 18, 2025

Molecular residual disease assessment in colorectal and bladder cancer by somatic structural variant analysis of cell-free DNA whole-genome sequencing data.

Molecular residual disease assessment in colorectal and bladder cancer by somatic structural variant analysis of cell-free DNA whole-genome sequencing data.

Journal: Journal of translational medicine

Published: September 05, 2025

Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy.

Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy.

Journal: Blood cancer journal

Published: February 17, 2025

Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score.

Diagnostic and Monitoring Strategies for VEXAS Syndrome: Evaluating Sanger Sequencing, NGS, and the SWIM-Score.

Journal: Journal of clinical immunology

Published: December 08, 2024

Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma.

Whole-genome Mutational Analysis for Tumor-informed Detection of Circulating Tumor DNA in Patients with Urothelial Carcinoma.

Journal: European urology

Published: March 08, 2024

Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.

Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.

Journal: Molecular oncology

Published: December 15, 2023

Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.

Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.

Journal: International journal of cancer

Published: August 15, 2023

Rare Case of a Turner Syndrome Patient with Metastatic Dysgerminoma and No Y-Chromosomal Material with Pathogenic Variants Found in KIT and MTOR.

Rare Case of a Turner Syndrome Patient with Metastatic Dysgerminoma and No Y-Chromosomal Material with Pathogenic Variants Found in KIT and MTOR.

Journal: Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation

Published: May 10, 2023

Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.

Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.

Journal: European urology

Published: March 28, 2023

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer.

Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer.

Journal: European urology open science

Published: March 13, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026